SAN FRANCISCO July 18 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced that the European Medicines Agency Committee for Orphan Medicinal Products COMP has issued a positive opinion on its application for orphan medicinal product status for ...
↧